Embedded Files
Liver Regeneration further reading
1. Hewitt, N. J. et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev. 39, 159–234 (2008).
2. Acosta, D., Anuforo, D. C., McMillin, R., Soine, W. H. & Smith, R. V. Comparison of cytochrome P-450 levels in adult rat liver, postnatal rat liver, and primary cultures of postnatal rat hepatocytes. Life Sci. 25, 1413–1418 (1979).
3. Guguen-Guillouzo, C. & Guillouzo, A. General review on in vitro hepatocyte models and their applications. Methods Mol. Biol. 640, 1–40 (2010).
4. Bissell, D. M., Arenson, D. M., Maher, J. J. & Roll, F. J. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J. Clin. Invest. 79, 801–812 (1987).
5. Dunn, J. C. Y., Yarmush, M. L., Koebe, H. G. & Tompkins, R. G. Hepatocyte function and extracellular matrix geometry: long‐term culture in a sandwich configuration. Faseb J. 3, 174–177 (1989).
6. Guguen-Guillouzo, C. et al. Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Exp. Cell Res 143, 47–54 (1983).
7. Clement, B. et al. Long‐term co‐cultures of adult human hepatocytes with rat liver epithelial cells: modulation of albumin secretion and accumulation of extracellular material. Hepatology 4, 373–380 (1984).
8. Mesnil, M., Fraslin, J.-M., Piccoli, C., Yamasaki, H. & Guguen-Guillouzo, C. Cell contact but not junctional communication (dye coupling) with biliary epithelial cells is required for hepatocytes to maintain differentiated functions. Exp. Cell Res. 173, 524–533 (1987).
9. Landry, J., Bernier, D., Ouellet, C., Goyette, R. & Marceau, N. Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J. Cell Biol. 101, 914–923 (1985).
10. Bachmann, A. et al. 3D cultivation techniques for primary human hepatocytes. Microarrays 4, 64–83 (2015).
11. Bell, C. C. et al. Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study. Toxicol. Sci. 162, 655–666 (2018).
12. Lauschke, V. M., Shafagh, R. Z., Hendriks, D. F. G. & Ingelman‐Sundberg, M. 3D primary hepatocyte culture systems for analyses of liver diseases, drug metabolism, and toxicity: emerging culture paradigms and applications. Biotechnol. J. 14, 1800347 (2019).
13. Ang, L. T. et al. A roadmap for human liver differentiation from pluripotent stem cells. Cell Rep. 22, 2190–2205 (2018).
14. Si‐Tayeb, K. et al. Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells. Hepatology 51, 297–305 (2010).
15. Cai, J. et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45, 1229–1239 (2007).
16. Wang, Q. et al. Generation of human hepatocytes from extended pluripotent stem cells. Cell Res. 30, 810–813 (2020).
17. Maepa, S. W. & Ndlovu, H. Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases. Stem Cells 38, 606–612 (2020).
18. Raju, R. et al. In vitro pluripotent stem cell differentiation to hepatocyte ceases further maturation at an equivalent stage of E15 in mouse embryonic liver development. Stem Cells Dev. 27, 910–921 (2018).
19. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009).
20. Huch, M. et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247–250 (2013).
21. Huch, M. et al. Long-term culture of genome-stable bipotent stem. Cells Adult Hum. Liver. Cell 160, 299–312 (2015).
22. Lugli, N. et al. R‐spondin 1 and noggin facilitate expansion of resident stem cells from non‐damaged gallbladders. EMBO Rep. 17, 769–779 (2016).
23. Sampaziotis, F. et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids. Nat. Med. 23, 954–963 (2017).
24. Rimland, C. A. et al. Regional differences in human biliary tissues and corresponding in vitro derived organoids. Hepatology https://doi.org/10.1002/ hep.31252 (2020).
25. Peng, W. C. et al. Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture. Cell 175, 1607–1619 (2018).
26. Hu, H. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175, 1591–1606 (2018). Peng et al. Experimental & Molecular Medicine (2021) 53:1512–1528 1525 Official journal of the Korean Society for Biochemistry and Molecular Biology
27. MacDONALD, R. A. Lifespan of liver cells: autoradiographic study using tritiated thymidine in normal, cirrhotic, and partially hepatectomized rats. Arch. Intern. Med. 107, 335–343 (1961).
28. Magami, Y. et al. Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver. Liver 22, 419–425 (2002).
29. Arrojo e Drigo, R. et al. Age mosaicism across multiple scales in adult tissues. Cell Metab. 30, 343–351 (2019).
30. Kudryavtsev, B. N., Kudryavtseva, M. V., Sakuta, G. A. & Stein, G. I. Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch. B 64, 387 (1993).
31. Miyajima, A., Tanaka, M. & Itoh, T. Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell 14, 561–574 (2014).
32. Wang, B., Zhao, L., Fish, M., Logan, C. Y. & Nusse, R. Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature 524, 180–185 (2015).
33. Rocha, A. S. et al. The angiocrine factor Rspondin3 is a key determinant of liver zonation. Cell Rep. 13, 1757–1764 (2015).
34. Planas-Paz, L. et al. The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size. Nat. Cell Biol. 18, 467–479 (2016).
35. Zhao, L. et al. Tissue repair in the mouse liver following acute carbon tetrachloride depends on injury‐induced Wnt/β‐catenin signaling. Hepatology 69, 2623–2635 (2019).
36. Tan, X., Behari, J., Cieply, B., Michalopoulos, G. K. & Monga, S. P. S. Conditional deletion of β-catenin reveals its role in liver growth and regeneration. Gastroenterology 131, 1561–1572 (2006).
37. Monga, S. P. β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology 148, 1294–1310 (2015).
38. Cairo, S. et al. Hepatic stem-like phenotype and interplay of Wnt/β-catenin and myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471–484 (2008).
39. Gröbner, S. N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321–327 (2018).
40. Clevers, H., Loh, K. M. & Nusse, R. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 346, 1248012 (2014).
41. Lau, W., de, Peng, W. C., Gros, P. & Clevers, H. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Gene Dev. 28, 305–316 (2014).
42. Lin, S. et al. Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury. Nature 556, 244–248 (2018).
43. Nault, J. C. et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat. Commun. 4, 2218 (2013).
44. Ang, C. H. et al. Lgr5+ pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis. Proc. Natl Acad. Sci. USA 116, 19530–19540 (2019).
45. Chen, F. et al. Broad distribution of hepatocyte proliferation in liver homeostasis and regeneration. Cell Stem Cell 26, 27–33 (2019).
46. Matsumoto, T., Wakefield, L., Tarlow, B. D. & Grompe, M. In vivo lineage tracing of polyploid hepatocytes reveals extensive proliferation during liver regeneration. Cell Stem Cell 26, 34–47 (2019).
47. Sun, T. et al. AXIN2+pericentral hepatocytes have limited contributions to liver homeostasis and regeneration. Cell Stem Cell 26, 97–107 (2019).
48. Font-Burgada, J. et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 162, 766–779 (2015).
49. Pek, N. M. Q., Liu, K. J., Nichane, M. & Ang, L. T. Controversies surrounding the origin of hepatocytes in adult livers and the in vitro generation or propa- gation of hepatocytes. Cell Mol. Gastroenterology Hepatology https://doi.org/10.1016/j.jcmgh.2020.09.016 (2020).
50. Heinke, P. et al. Diploid hepatocytes drive physiological liver renewal in adult humans. Biorxiv https://doi.org/10.1101/2020.08.07.230086 (2020).
51. Taub, R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5, 836–847 (2004).
52. Michalopoulos, G. K. Hepatostat: liver regeneration and normal liver tissue maintenance. Hepatology 65, 1384–1392 (2017).
53. Michalopoulos, G. K. Liver regeneration. J. Cell Physiol. 213, 286–300 (2007).
54. Bucher, M. L. & Swaffield, M. N. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc. Natl Acad. Sci. USA72, 1157–1160 (1975).
55. Michalopoulos, G. K. Liver regeneration after partial hepatectomy critical analysis of mechanistic dilemmas. Am. J. Pathol. 176, 2–13 (2010).
56. Marubashi, S. et al. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 136, 1028–1037 (2004).
57. Niehrs, C. & Acebron, S. P. Mitotic and mitogenic Wnt signalling. Embo J. 31, 2705–2713 (2012).
58. Peng, W. C. et al. Structure of stem cell growth factor R-spondin 1 in complex with the ectodomain of its receptor LGR5. Cell Rep. 3, 1885–1892 (2013).
59. Peng, W. C. et al. Structures of Wnt-Antagonist ZNRF3 and its complex with R-Spondin 1 and implications for signaling. PLoS ONE 8, e83110 (2013).
60. Ding, B.-S. et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468, 310–315 (2010).
61. Cerami, A. Inflammatory cytokines. Clin. Immunol. Immunop 62, S3–S10 (1992).
62. Cornell, R. P. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am. J. Physiol.-regulatory Integr. Comp. Physiol. 249, R551–R562 (1985).
63. Michalopoulos, G. K. & Bhushan, B. Liver regeneration: biological and pathological mechanisms and implications. Nat. Rev. Gastroenterol. https:// doi.org/10.1038/s41575-020-0342-4 (2020).
64. Tsai, S.-M. & Wang, W.-P. Expression and function of fibroblast growth factor (FGF) 7 during liver regeneration. Cell Physiol. Biochem. 27, 641–652 (2011).
65. Kong, B. et al. Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am. J. Physiol.-gastr L 306, G893–G902 (2014).
66. Sugimoto, H. et al. BMP‐7 functions as a novel hormone to facilitate liver regeneration. FASEB J. 21, 256–264 (2007).
67. Michalopoulos, G. K. In The Liver: Biology and Pathobiology 6th edn (eds Arias, I. M. et al.) Ch. 45 (Wiley-Blackwell, Hoboken, 2020).
68. Yimlamai, D., Fowl, B. H. & Camargo, F. D. Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer. J. Hepatol. 63, 1491–1501 (2015).
69. Patel, S. H., Camargo, F. D. & Yimlamai, D. Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis. Gastroenterology 152, 533–545 (2017).
70. Walker, P. R. & Potter, V. R. Isozyme studies on adult, regenerating, precancerous and developing liver in relation to findings in hepatomas. Adv. Enzym. Regul. 10, 339–364 (1972).
71. Bonney, R. J., Hopkins, H. A., Walker, P. R. & Potter, V. R. Glycolytic isoenzymes and glycogen metabolism in regenerating liver from rats on controlled feeding schedules. Biochem J. 136, 115–124 (1973).
72. Campbell, J. S. et al. Expression of suppressors of cytokine signaling during liver regeneration. J. Clin. Invest. 107, 1285–1292 (2001).
73. Brand, S. et al. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am. J. Physiol.-Gastr. L 292, G1019–G1028 (2007).
74. Sun, R. & Gao, B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-γ). Gastroenterology 127, 1525–1539 (2004).
75. Katsuda, T. et al. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell 20, 41–55 (2017).
76. Broutier, L. et al. Human primary liver cancer–derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424–1435 (2017).
77. Mitaka, T., Mikami, M., Sattler, G. L., Pitot, H. C. & Mochizuki, Y. Small cell colonies appear in the primary culture of adult rat hepatocytes in the presence of nicotinamide and epidermal growth factor. Hepatology 16, 440–447 (1992).
78. Akerman, P. et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol.-Gastr L 263, G579–G585 (1992).
79. Cressman, D. E. et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379–1383 (1996).
80. Yamada, Y., Kirillova, I., Peschon, J. J. & Fausto, N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl Acad. Sci. USA 94, 1441–1446 (1997).
81. Sérandour, A. et al. TNFα‐mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology 41, 478–486 (2005).
82. Kamiya, A. & Gonzalez, F. J. TNF‐α regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices. Hepatology 40, 527–536 (2004).
83. Beg, A. A. & Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782–784 (1996). Peng et al. Experimental & Molecular Medicine (2021) 53:1512–1528 1526 Official journal of the Korean Society for Biochemistry and Molecular Biology
84. Papa, S., Bubici, C., Zazzeroni, F. & Franzoso, G. Mechanisms of liver disease: cross-talk between the NF-κB and JNK pathways. Biol. Chem. 390, 965–976 (2009).
85. Ma, B. & Hottiger, M. O. Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation. Front Immunol. 7, 378 (2016).
86. Hyun, J. et al. Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis. J. Clin. Invest 130, 2129–2145 (2020).
87. Aurora, A. B. & Olson, E. N. Immune modulation of stem cells and regeneration. Cell Stem Cell 15, 14–25 (2014).
88. Karin, M. & Clevers, H. Reparative inflammation takes charge of tissue regeneration. Nature 529, 307–315 (2016).
89. Fu, X. et al. Combination of inflammation-related cytokines promotes long-term muscle stem cell expansion. Cell Res 25, 655–673 (2015).
90. Katsura, H., Kobayashi, Y., Tata, P. R. & Hogan, B. L. M. IL-1 and TNFα contribute to the inflammatory niche to enhance alveolar regeneration. Stem Cell Rep. 12, 657–666 (2019).
91. Choi, J. et al. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell 27, 366–382 (2020).
92. Takase, H. M. et al. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Gene Dev. 27, 169–181 (2013).
93. Lázaro, C. A. et al. Establishment, characterization, and long‐term maintenance of cultures of human fetal hepatocytes. Hepatology 38, 1095–1106 (2003).
94. Ng, S. S. et al. Long-term culture of human liver tissue with advanced hepatic functions. Jci Insight 2, e90853 (2017).
95. Kim, Y. et al. Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells. J. Hepatol. 70, 97–107 (2018).
96. Zhang, K. et al. In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell 23, 806–819 (2018).
97. Xiang, C. et al. Long-term functional maintenance of primary human hepatocytes in vitro. Science 364, 399–402 (2019).
98. Fu, G.-B. et al. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Res 29, 8–22 (2019).
99. Unzu, C. et al. Pharmacological induction of a progenitor state for the efficient expansion of primary human hepatocytes. Hepatology 69, 2214–2231 (2019).
100. Katsuda, T. et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. Elife 8, e47313 (2019).
101. Walldorf, J. et al. Expanding hepatocytes in vitro before cell transplantation: donor age‐dependent proliferative capacity of cultured human hepatocytes. Scand. J. Gastroentero 39, 584–593 (2009).
102. Michalopoulos, G. K., Bowen, W. C., Mulè, K., Lopez‐Talavera, J. C. & Mars, W. Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures. Hepatology 36, 278–283 (2002).
103. Michalopoulos, G. K., Barua, L. & Bowen, W. C. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 41, 535–544 (2005).
104. Yanger, K. et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Gene Dev. 27, 719–724 (2013).
105. Schaub, J. R. et al. De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation. Nature 557, 247–251 (2018).
106. Costa, R. H., Kalinichenko, V. V., Holterman, A. L. & Wang, X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38, 1331–1347 (2003).
107. Su, T. et al. Two-signal requirement for growth-promoting function of Yap in hepatocytes. Elife 4, e02948 (2015).
108. Michalopoulos, G. K. & DeFrances, M. C. Liver regeneration. Science 276, 60–66 (1997).
109. Shimizu, H. et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J. Hepatol. 34, 683–689 (2001).
110. Shimizu, H. et al. Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats. World J. Gastroenterol. 11, 7254–7260 (2005).
111. Chembazhi, U. V., Bangru, S., Hernaez, M. & Kalsotra, A. Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver. Biorxiv https://doi.org/10.1101/2020.05.29.124263 (2020).
112. Schaum, N. et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562, 367–372 (2018).
113. Halpern, K. B. et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542, 352–356 (2017).
114. Benhamouche, S. et al. Apc tumor suppressor gene is the “Zonation-Keeper” of mouse liver. Dev. Cell 10, 759–770 (2006).
115. Hailfinger, S., Jaworski, M., Braeuning, A., Buchmann, A. & Schwarz, M. Zonal gene expression in murine liver: lessons from tumors. Hepatology 43, 407–414 (2006).
116. Cheng, X. et al. Glucagon contributes to liver zonation. Proc. Natl Acad. Sci. USA 115, E4111–E4119 (2018).
117. Michalopoulos, G. K., Bowen, W. C., Mulé, K. & Luo, J. HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr. 11, 55–75 (2003).
118. Jungermann, K. & Keitzmann, T. Zonation of parenchymal and non-parenchymal metabolism in liver. Annu Rev. Nutr. 16, 179–203 (1996).
119. Halpern, K. B. et al. Paired-cell sequencing enables spatial gene expression mapping of liver endothelial cells. Nat. Biotechnol. 36, 962–970 (2018).
120. Janda, C. Y. et al. Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling. Nature 545, 234–237 (2017).
121. Miao, Y. et al. Next-generation surrogate Wnts support organoid growth and deconvolute frizzled pleiotropy in vivo. Cell Stem Cell 27, 840–851 (2020).
122. Habib, S. J. et al. A localized Wnt signal orients asymmetric stem cell division in vitro. Science 339, 1445–1448 (2013).
123. Lowndes, M., Rotherham, M., Price, J. C., El Haj, A. J. & Habib, S. J. Immobilized WNT proteins act as a stem cell niche for tissue engineering. Stem Cell Rep. 7, 126–137 (2016).
124. Lowndes, M., Junyent, S. & Habib, S. J. Constructing cellular niche properties by localized presentation of Wnt proteins on synthetic surfaces. Nat. Protoc. 12, 1498–1512 (2017).
125. Brassard, J. A., Nikolaev, M., Hübscher, T., Hofer, M. & Lutolf, M. P. Recapitulating macro-scale tissue self-organization through organoid bioprinting. Nat. Mater. https://doi.org/10.1038/s41563-020-00803-5 (2020).
126. Schneider, A. et al. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 82, 1115–1116 (2006).
127. Dhawan, A. et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78, 1812–1814 (2004).
128. Fox, I. J. et al. Treatment of the Crigler–Najjar syndrome type I with hepa-
tocyte transplantation. N. Engl. J. Med. 338, 1422–1427 (1998).
129. Ambrosino, G. et al. Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transpl. 14, 151–157 (2005).
130. Lysy, P. A. et al. Liver cell transplantation for Crigler-Najjar syndrome type I: Update and perspectives. World J. Gastroenterol 14, 3464–3470 (2008).
131. Barahman, M. et al. Hepatocyte transplantation: Quo Vadis? Int J. Radiat. Oncol. Biol. Phys. 103, 922–934 (2018).
132. Soltys, K. A. et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J. Hepatol. 66, 987–1000 (2017).
133. Terry, C., Dhawan, A., Mitry, R. R. & Hughes, R. D. Cryopreservation of isolated human hepatocytes for transplantation: state of the art. Cryobiology 53, 149–159 (2006).
134. Gómez-Lechón, M. J., Lahoz, A., Jiménez, N., Castell, J. V. & Donato, M. T. Cryopreservation of rat, dog and human hepatocytes: influence of preculture and cryoprotectants on recovery, cytochrome P450 activities and induction upon thawing. Xenobiotica 36, 457–472 (2008).
135. Tarlow, B. D., Finegold, M. J. & Grompe, M. Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury. Hepatology 60, 278–289 (2014).
136. Yanger, K. et al. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 15, 340–349 (2014).
137. Raven, A. et al. Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration. Nature 547, 350–354 (2017).
138. Grompe, M. et al. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 7, 2298–2307 (1993).
139. Azuma, H. et al. Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice. Nat. Biotechnol. 25, 903–910 (2007).
140. Overturf, K. et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat. Genet 12, 266–273 (1996).
141. Russell, J. O. Wnt/β-catenin signaling in liver development, homeostasis, and pathobiology. Annu. Rev. Pathol. 13, 351–378 (2018). Peng et al. Experimental & Molecular Medicine (2021) 53:1512–1528 1527 Official journal of the Korean Society for Biochemistry and Molecular Biology
142. Taniguchi, E., Sakisaka, S., Matsuo, K., Tanikawa, K. & Sata, M. Expression and Role of Vascular Endothelial Growth Factor in Liver Regeneration After Partial Hepatectomy in Rats. J. Histochem Cytochem 49, 121–129 (2000).
143. Ding, J. et al. Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytes. J. Clin. Invest 121, 1930–1934 (2011).
144. Wang, M.-J. et al. Insulin-like growth factor 2 is a key mitogen driving liver repopulation in mice. Cell Death Dis. 9, 26 (2018).
145. Liu, J. et al. Pericentral hepatocytes produce insulin‐like growth factor‐2 to promote liver regeneration during selected injuries in mice. Hepatology 66, 2002–2015 (2017).
146. Benten, D. et al. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology 42, 1072–1081 (2005).
147. Dusabineza, A.-C. et al. Hepatic stellate cells improve engraftment of human primary hepatocytes: a preclinical transplantation study in an animal model. Cell Transpl. 24, 2557–2571 (2014).
148. Oldhafer, F., Bock, M., Falk, C. S. & Vondran, F. W. R. Immunological aspects of liver cell transplantation. World J. Transpl. 6, 42 (2016).
149. Nagy, P., Thorgeirsson, S. S. & Grisham, J. W. In The Liver: Biology and Pathobiology 6th edn (eds Arias, I. M. et al.) Ch. 1 (Wiley-Blackwell, Hoboken, 2020).
150. Guha, C. et al. Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36, 354–362 (2002).
151. Yamanouchi, K. et al. Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology 49, 258–267 (2009).
152. Grompe, M. & Al-Dhalimy, M. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, Type I. Hum. Mutat. 2, 85–93 (1993).
153. Lomas, D. A., LI-Evans, D., Finch, J. T. & Carrell, R. W. The mechanism of Z α1- antitrypsin accumulation in the liver. Nature 357, 605–607 (1992).
154. Bilir, B. M. et al. Hepatocyte transplantation in acute liver failure. Liver Transpl. 6, 32–40 (2000).
155. Bernal, W., Auzinger, G., Dhawan, A. & Wendon, J. Acute liver failure. Lancet 376, 190–201 (2010).
156. Rela, M., Kaliamoorthy, I. & Reddy, M. S. Current status of auxiliary partial orthotopic liver transplantation for acute liver failure. Liver Transpl. 22, 1265–1274 (2016).
157. Fisher, R. A. & Strom, S. C. in The Hepatocyte Review (M. N. Berry, A. M. Edwards eds) Ch. 28 (Kluwer Academic Publishers, Amsterdam, 2000)
158. Guan, Y. et al. Human hepatic organoids for the analysis of human genetic diseases. JCI Insight 2, e94954 (2017).
159. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
160. Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770–788 (2018).
161. Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
162. Marzec, M., Brąszewska-Zalewska, A. & Hensel, G. rime editing: a new way for genome editing. Trends Cell Biol. 30, 257–259 (2020).
163. Artegiani, B. et al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR–Cas9 precision genome editing. Nat. Cell Biol. 22, 321–331 (2020).
164. VanLith, C. J. et al. Ex vivo hepatocyte reprograming promotes homology‐ directed DNA repair to correct metabolic disease in mice after transplantation. Hepatol. Commun. 3, 558–573 (2019).
165. Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97–110 (2020).
166. Murillo, O. et al. Gene therapy of Wilson disease: A “golden” opportunity using rAAV on the 50th anniversary of the discovery of the virus. J. Hepatol. 64, 265–267 (2016).
Page updated
Google Sites
Report abuse